2-38666308-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_138801.3(GALM):c.147G>A(p.Gln49Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00692 in 1,613,702 control chromosomes in the GnomAD database, including 655 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 359 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 296 hom. )
Consequence
GALM
NM_138801.3 synonymous
NM_138801.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.765
Genes affected
GALM (HGNC:24063): (galactose mutarotase) This gene encodes an enzyme that catalyzes the epimerization of hexose sugars such as glucose and galactose. The encoded protein is expressed in the cytoplasm and has a preference for galactose. The encoded protein may be required for normal galactose metabolism by maintaining the equilibrium of alpha and beta anomers of galactose.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 2-38666308-G-A is Benign according to our data. Variant chr2-38666308-G-A is described in ClinVar as [Benign]. Clinvar id is 1259664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.765 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.129 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALM | NM_138801.3 | c.147G>A | p.Gln49Gln | synonymous_variant | 1/7 | ENST00000272252.10 | NP_620156.1 | |
GALM | XM_011532540.3 | c.147G>A | p.Gln49Gln | synonymous_variant | 1/6 | XP_011530842.1 | ||
GALM | XM_047443419.1 | c.147G>A | p.Gln49Gln | synonymous_variant | 1/6 | XP_047299375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALM | ENST00000272252.10 | c.147G>A | p.Gln49Gln | synonymous_variant | 1/7 | 1 | NM_138801.3 | ENSP00000272252.5 | ||
GALM | ENST00000410063.5 | c.147G>A | p.Gln49Gln | synonymous_variant | 1/4 | 3 | ENSP00000386233.1 | |||
GALM | ENST00000427858.4 | n.228G>A | non_coding_transcript_exon_variant | 1/4 | 4 | |||||
GALM | ENST00000444351.5 | n.66G>A | non_coding_transcript_exon_variant | 1/7 | 5 | ENSP00000409083.1 |
Frequencies
GnomAD3 genomes AF: 0.0377 AC: 5737AN: 152160Hom.: 358 Cov.: 32
GnomAD3 genomes
AF:
AC:
5737
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00967 AC: 2424AN: 250580Hom.: 150 AF XY: 0.00706 AC XY: 956AN XY: 135456
GnomAD3 exomes
AF:
AC:
2424
AN:
250580
Hom.:
AF XY:
AC XY:
956
AN XY:
135456
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00371 AC: 5419AN: 1461424Hom.: 296 Cov.: 31 AF XY: 0.00311 AC XY: 2260AN XY: 727000
GnomAD4 exome
AF:
AC:
5419
AN:
1461424
Hom.:
Cov.:
31
AF XY:
AC XY:
2260
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0377 AC: 5747AN: 152278Hom.: 359 Cov.: 32 AF XY: 0.0359 AC XY: 2673AN XY: 74472
GnomAD4 genome
AF:
AC:
5747
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
2673
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
GALM-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at